Novo Nordisk Files Nine Suits Over Ozempic, Wegovy Copycats

Novo Nordisk A/S filed nine separate lawsuits accusing compounding pharmacies, weight-loss clinics, medical spas and other outlets of selling knockoff medications related to its popular drugs Wegovy and Ozempic—and in some cases of infringing the names’ trademarks.

The nine lawsuits all target businesses Novo Nordisk said sell products supposedly containing semaglutide, the active ingredient in its injectible treatments for Type 2 diabetes and weight loss, according to the complaints filed Thursday in Florida, Colorado, Montana, Texas, and Illinois federal courts.

All of the complaints allege the defendants violate various applicable federal and state false advertising, deceptive trade practices, and unfair ...